Objective: To determine whether naloxone administration after hemorrhagic s
hock has any beneficial or deleterious effect on immune responses.
Background Data: Hemorrhagic shock is known to produce immunodepression in
both humans and experimental animals. Although studies suggest that endogen
ous opioids play a role in immune regulation in adverse circulatory conditi
ons, it remains controversial whether these opioids exert beneficial or det
rimental effects on immunity after shock. Moreover, little information is a
vailable concerning the effects of opioid receptor blockade using naloxone
on cell-mediated immunity and endocrine responses after shock.
Methods: Male C3H/HeN mice (25 g) were bled to and maintained at a mean art
erial blood pressure of 35 +/- 5 mm Hg for 1 hr, The shed blood was then re
turned along with lactated Ringer's solution (two times the shed blood volu
me) to provide fluid resuscitation, The animals were randomized to receive
either naloxone (1 mg/kg iv) or an equal volume of vehicle (saline) after t
he shed blood was returned, i.e., immediately before crystalloid resuscitat
ion, and were killed at 2 hrs after resuscitation to obtain splenocytes, ma
crophages (peritoneal and splenic), and blood.
Measurements and Main Results: Bioassays revealed significantly decreased r
elease of all studied interleukins (interleukins-1, -2, -3, and -6) by peri
toneal and splenic macrophages as well as significantly decreased splenocyt
e proliferative capacity after shock in vehicle-treated mice, Naloxone admi
nistration after hemorrhage resulted in either similar or even more decreas
ed levels of interleukin release compared with vehicle-treated hemorrhaged
mice. Significantly increased plasma corticosterone concentrations were obs
erved in vehicle-treated animals compared with control animals. Naloxone ad
ministration did not have any significant effects on corticosterone plasma
concentrations after hemorrhage.
Conclusions: These findings indicate the importance of the endogenous opioi
d system for the maintenance of immunity in adverse circulatory conditions,
i.e., hemorrhage. Although additional studies involving different doses an
d/or times of naloxone administration may provide different results, the pr
esent findings raise the concern that naloxone administration in the trauma
tized host may have deleterious effects because it decreases peritoneal mac
rophage and splenic immune functions.